Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone in Acute Heart Failure
NCT04163588Phase 3Unknown
- Sponsor
- Policlinico Casilino
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metolazone in Acute Heart Failure (AHF) (2 arms), sponsored by Policlinico Casilino. Primary endpoint: Change in serum creatinine level and change in weight at 72 hours. Status: unknown.
02
Drugs
metolazone
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04163588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04163588.